Canada-based Tekna announced it has received a titanium metal powder order from a US contract manufacturer of medical implants, valued at CAD 1.2 million, with delivery expected throughout 2027. This follows a CAD 1.6 million Ti64 order from a European medical distributor in October, marking a new customer for Tekna in the medical implant market and confirming the ongoing penetration of its plasma atomization powder production in the implant sector. The disclosure was made via the Oslo Stock Exchange Newsweb (#685451). Source: TDN Direkt / Finansavisen (Norwegian primary financial media)